Master's Theses in Drug Sciences
The Master's thesis gives students the opportunity to apply and expand their learned skills within 10-month project in the fields of pharmaceutical research (university or industry). Students conduct independent, scientific work and gain insight into a scientific research group. The project is carried out during the 3rd and 4th study semester and is concluded with a written report. Within four weeks after submission, students take an oral exam (presentation of their work and colloquium).
Prerequisites: The Master's thesis is a full-time project concluding the program. The first two semesters must have been completed (max. 3 ECTS missing from the compulsory curriculum). Please inform (potential) supervisors of your study progress.
Required forms for acquiring credit points (no further registration in MOnA required) as well as information sheets can be found under "Documents".
Refer to the overview of each Research Group for the current Master's Theses-Projects
External Master's Theses Projects
| Forschungsgebiet Research field | Kontakt BetreuerIn Contact Supervisor | MSc Pharmazie | MSc Drug Sciences | Bemerkungen Comments |
|---|---|---|---|---|
Automated preparation of personalized medicines Personalized medicine represents a paradigm shift from traditional “one-size-fits-all” pharmacotherapy toward individualized dose preparation at the point of care. This approach is particularly valuable in pediatrics, where commercially available dosage strengths often fail to meet individual patient requirements. The Medimaker-1 platform provides a versatile solution for automated preparation of personalized oral dosage forms, such as blister-based gel tablets and capsules. This technology enables precise dosing and scalable small-batch manufacturing directly at hospital pharmacies or other compounding facilities. The aims of the thesis are to develop semi-solid formulations suitable for filling capsules and blister molds, and to evaluate critical process parameters of the Medimaker-1 filling process. Drugs commonly administered in pediatric patients will be selected for potential clinical application at the University Hospital Basel. Start: April 2026 or later | Daniel Preisig | no | yes | |
| The Translational Hepatology Laboratory, lead by Christine Bernsmeier, investigates liver cirrhosis, a complex systemic inflammatory disease with high morbidity, mortality, and infectious complications. | Prof. Dr. Christine Bernsmeier | no | yes | Description |
| Microfluidic tools to monitor and study microbial cells | Dr. Petra Juskova | no | yes | Description |
| Establishment and validation of new LC-MS methods in the field of toxicology | Dr. Katharina Rentsch | no | yes | Description |
Please take note of the period of grace by the rector's office for the completion of the Master's thesis and the Master's examination up to the beginning of the ensuing semester:
Assessments/grades for degrees, which arrive at the Office of the Dean of Studies (Studiendekanat Phil.-nat.) before the beginning of the new semester (cp. semester dates) can still be counted as academic achievements in the "old" semester and students do not have to re-enroll again. After this deadline, there is no more scope and students have to enroll again (paying the whole tuition fees)!
Departmental Logo: This may be used within the Department of Pharmaceutical Sciences in compliance with the information provided in the user manual.